EPOFIT 2000 IU INJECTION

Epofit 2000 IU injection contains active ingredients like Recombinant human erythropoietin Alfa/ep. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The medication is used to treat anaemia that is caused by chronic kidney illness (CKD), as well as chemotherapy for cancer or HIV treatment with zidovudine. It also decreases the need for transfusions of red blood cells for patients at risk of blood loss as a result of surgery planned and other surgical procedures.
Epofit 2000 IU injection shouldn’t be administered to patients suffering from excessive hypertension or one of the components thereof, active thrombotic microangiopathy (TMA) and purified red cell aplasia (PRCA) seizures that are uncontrolled, as well as lactation or pregnancy. It is also recommended to use it carefully in patients who have a background of bleeding clots or heart disease, kidney disease, stroke, liver disease, thalassemia, sickle cell anaemia (SCA), myelodysplastic disorder, cancer, or leukaemia. It should not be used for children younger than 18 years old in cases where the benefits are greater than the risks. Older adults taking this medication must be monitored closely for any adverse effects. Before beginning this treatment, you must consult your physician regarding the dangers and benefits of Epofit  2000 IU injectionn dose.